Article | September 29, 2022

Combatting Counterfeit Med Devices And Pharmaceuticals: Serialization, Validation, And A Case For Digital Transformation

By Brian Freymann

magnifying glass w pills 450x300

The manufacture, sales, and distribution of counterfeit medications and medical devices is a persistent and growing problem worldwide. The financial loss to manufacturers to develop compliant products and adhere to FDA software validation and regulated GxP standards is significant, but the resulting risks to patient health from counterfeit pharmaceuticals and medical devices that neglect software validation for medical device manufacturing can cause adverse long-term consequences or even death.

As regulators continue to align, pharma and medical manufacturers have a unique opportunity to adopt serialization compliance while positioning themselves for improved operational value by linking their serialization program to a modern ERP system. Continue reading to learn how an enterprise-grade system manages the needs of a serialization effort both internally within the operational confines of the manufacturer and the broader big data networks and supply chain ecosystems.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online